📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Synthesis and Biological Evaluation of Cyclobutane-Based ß3 Integrin Antagonists: A Novel Approach to Targeting Integrins for Cancer Therapy. (2023)

First Author: Sutherland M
Attributed to:  Design, synthesis and applications of chiral cyclobutanes funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cancers15164023

PubMed Identifier: 37627051

Publication URI: http://europepmc.org/abstract/MED/37627051

Type: Journal Article/Review

Volume: 15

Parent Publication: Cancers

Issue: 16

ISSN: 2072-6694